Using Flow Cytometry to Study Myc's Role in Shaping the Tumor Immune Microenvironment

Sílvia Casacuberta-Serra1

  • 1Peptomyc S.L., Barcelona, Spain. scasacuberta@peptomyc.com.

Summary

The MYC oncogene drives cancer progression and immune evasion. Inhibiting MYC may reverse these effects, enabling anti-tumor immunity by analyzing tumor-infiltrating lymphocytes.

Related Concept Videos